Joseph P Thompson1, Davinia Bennett2, James Hodson3, Miriam Asia4,5, John Ayuk4,5, Michael W O'Reilly4,5,6, Niki Karavitaki4,5,6, Wiebke Arlt4,5,6, Robert P Sutcliffe1. 1. HPB Surgery Unit, Queen Elizabeth Hospital Birmingham, Birmingham, UK. 2. Anaesthetic Department, Queen Elizabeth Hospital Birmingham, Birmingham, UK. 3. Department of Biostatistics, Institute of Translational Medicine, Queen Elizabeth Hospital Birmingham, Birmingham, UK. 4. Department of Endocrinology, Queen Elizabeth Hospital Birmingham, Birmingham, UK. 5. Institute of Metabolism and Systems Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK. 6. Centre for Endocrinology, Diabetes and Metabolism, Birmingham Health Partners, Birmingham, UK.
Abstract
BACKGROUND: Due to risk of haemodynamic instability (HDI), it has been recommended that patients undergoing adrenalectomy for phaeochromocytoma should be monitored in an intensive care facility. The aim of this study was to evaluate the incidence, risk factors and outcomes of postoperative HDI in these patients. Retrospective cohort study of 46 consecutive patients who underwent open (OA, N=26) or laparoscopic (LA, N=20) adrenalectomy for phaeochromocytoma at a single centre [2007-2017]. METHODS: HDI was defined as systolic BP >200 or <90 mmHg, heart rate >120 or <50 bpm or vasopressor therapy within 24 hours. Risk factors for intraoperative and postoperative HDI were evaluated by univariable and multivariable analyses. RESULTS: Intraoperative hypertension occurred in 25/42 patients (60%). Preoperative plasma normetanephrine levels ≥3,500 pmol/L were significantly associated with intraoperative hypertension on multivariable analysis [odds ratio (OR) 42; 95% CI: 4-429; P=0.002). Postoperative hypotension occurred in 21/45 patients (47%), and 13 (29%) required vasopressor therapy. Preoperative beta-blockade therapy was the only independent risk factor for postoperative hypotension on multivariable analysis (OR 4.0; 95% CI: 1.2-13.9, P=0.029). No patients (0/9) with tumours <5 cm treated by LA needed postoperative vasopressor therapy, compared to 39% (7/18) treated by OA (P=0.059). Complications developed in 9 patients (20%), and were less likely in those with intraoperative hypertension (8% vs. 41%; P=0.019). There was one postoperative death. CONCLUSIONS: Preoperative beta-blockade therapy is an independent risk factor for postoperative HDI after adrenalectomy for phaeochromocytoma. Patients who undergo laparoscopic adrenalectomy (LA) for phaeochromocytomas <5 cm are unlikely to need postoperative vasopressor therapy, and may not require intensive care monitoring. 2019 Gland Surgery. All rights reserved.
BACKGROUND: Due to risk of haemodynamic instability (HDI), it has been recommended that patients undergoing adrenalectomy for phaeochromocytoma should be monitored in an intensive care facility. The aim of this study was to evaluate the incidence, risk factors and outcomes of postoperative HDI in these patients. Retrospective cohort study of 46 consecutive patients who underwent open (OA, N=26) or laparoscopic (LA, N=20) adrenalectomy for phaeochromocytoma at a single centre [2007-2017]. METHODS: HDI was defined as systolic BP >200 or <90 mmHg, heart rate >120 or <50 bpm or vasopressor therapy within 24 hours. Risk factors for intraoperative and postoperative HDI were evaluated by univariable and multivariable analyses. RESULTS: Intraoperative hypertension occurred in 25/42 patients (60%). Preoperative plasma normetanephrine levels ≥3,500 pmol/L were significantly associated with intraoperative hypertension on multivariable analysis [odds ratio (OR) 42; 95% CI: 4-429; P=0.002). Postoperative hypotension occurred in 21/45 patients (47%), and 13 (29%) required vasopressor therapy. Preoperative beta-blockade therapy was the only independent risk factor for postoperative hypotension on multivariable analysis (OR 4.0; 95% CI: 1.2-13.9, P=0.029). No patients (0/9) with tumours <5 cm treated by LA needed postoperative vasopressor therapy, compared to 39% (7/18) treated by OA (P=0.059). Complications developed in 9 patients (20%), and were less likely in those with intraoperative hypertension (8% vs. 41%; P=0.019). There was one postoperative death. CONCLUSIONS: Preoperative beta-blockade therapy is an independent risk factor for postoperative HDI after adrenalectomy for phaeochromocytoma. Patients who undergo laparoscopic adrenalectomy (LA) for phaeochromocytomas <5 cm are unlikely to need postoperative vasopressor therapy, and may not require intensive care monitoring. 2019 Gland Surgery. All rights reserved.
Authors: Cassandre E Bénay; Mehdi Tahiri; Lawrence Lee; Evangelia Theodosopoulos; Amin Madani; Liane S Feldman; Elliot J Mitmaker Journal: Surgery Date: 2015-10-02 Impact factor: 3.982
Authors: J L Joris; E E Hamoir; G M Hartstein; M R Meurisse; B M Hubert; C J Charlier; M L Lamy Journal: Anesth Analg Date: 1999-01 Impact factor: 5.108
Authors: Colleen M Kiernan; Liping Du; Xi Chen; James T Broome; Chanjuan Shi; Mary F Peters; Carmen C Solorzano Journal: Ann Surg Oncol Date: 2014-06-18 Impact factor: 5.344
Authors: Magdalena Pisarska-Adamczyk; Karolina Zawadzka; Krzysztof Więckowski; Krzysztof Przęczek; Piotr Major; Michał Wysocki; Piotr Małczak; Michał Pędziwiatr Journal: Gland Surg Date: 2021-03